GREAT NECK, N.Y., Dec. 9 /PRNewswire/ --Scarguard Labs, LLC, a closely held company specializing in the treatment of scars and other dermatological problems through the use of multi-technology drugs enhanced by a proprietary contact delivery system, announced it has agreements in place with Publix Supermarkets and McKesson Drugs to carry Scarguard products.
"These are very positive developments for Scarguard," said CEO Joel Studin. "McKesson is the largest drug wholesaler in the U.S., with more than 20 distribution centers across the country. Publix is the fourth largest grocery store chain in the U.S., and caters to a high-end clientele through its 450 stores across the Southeast.
"The McKesson agreement complements our existing agreements with Amerisource Bergen and Cardinal Health, and means that we have agreements with the three largest pharmaceutical distributors. This will give our products enormous visibility to retail customers across the country and with large independent drugstores chains in particular. The agreement immediately placed our products in McKesson's two largest retailers, and as a result, we have seen at least a 15% increase in the dollar volume of our sales.
"The Publix clientele is precisely the target market for Scarguard products," continued Studin. "It has been a long time goal of ours to reach an agreement with them. Eventually Publix came to believe that our products are the most efficacious of the category and saw our successes in other food chains such as ShopRite and Pathmark. We consider this agreement to be a highlight of our strategy to increase the retail presence for our products by expanding our presence in other channels."
About Scarguard Labs, LLC
Scarguard Labs, LLC is a closely held pharmaceutical company specializing in dermatological medications employing an internationally patented delivery system designed to enhance drug effectiveness utilizing a multi-technology approach. Our flagship product, Scarguard, is the most frequently dispensed product for scars in plastic surgery offices since 2001. In addition, it can be found in most pharmacies, drug distributors and major grocery chains throughout the United States. We have multiple topical prescription and non-prescription drugs in the marketplace, or in varying stages of development For more information, please visit our website at www.scarguard.com.
Company Contact: Investor Relations: Richard E. Pino John McNamara Chief Financial Officer/Investor Relations Cameron Associates Scarguard Labs, LLC (212) 245-8800 Ext. 205 516-482-8050 firstname.lastname@example.org Richard@scarguard.com
|SOURCE Scarguard Labs, LLC|
Copyright©2008 PR Newswire.
All rights reserved